tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Hikma Pharmaceuticals Executives Increase Shareholdings
Company AnnouncementsHikma Pharmaceuticals Executives Increase Shareholdings
2d ago
Hikma Pharmaceuticals Updates 2025 Guidance and Medium-Term Outlook
PremiumCompany Announcements
Hikma Pharmaceuticals Updates 2025 Guidance and Medium-Term Outlook
3d ago
Hikma Pharmaceuticals Executives Acquire Shares, Signaling Confidence
PremiumCompany Announcements
Hikma Pharmaceuticals Executives Acquire Shares, Signaling Confidence
2M ago
Hikma Pharmaceuticals Executive Vice Chairman Acquires Shares
PremiumCompany Announcements
Hikma Pharmaceuticals Executive Vice Chairman Acquires Shares
2M ago
Hikma Pharmaceuticals Director Acquires Shares, Signaling Confidence
PremiumCompany Announcements
Hikma Pharmaceuticals Director Acquires Shares, Signaling Confidence
3M ago
Hikma Pharmaceuticals Executive Exercises Share Options
PremiumCompany AnnouncementsHikma Pharmaceuticals Executive Exercises Share Options
3M ago
Hikma Pharmaceuticals’ Earnings Call: Mixed Financial Performance
Premium
Company Announcements
Hikma Pharmaceuticals’ Earnings Call: Mixed Financial Performance
3M ago
Hikma Pharmaceuticals Executive Vice Chairman Acquires Significant Shareholding
Premium
Company Announcements
Hikma Pharmaceuticals Executive Vice Chairman Acquires Significant Shareholding
3M ago
Hikma Pharmaceuticals Reports Strong H1 2025 Performance and Positive Outlook
PremiumCompany Announcements
Hikma Pharmaceuticals Reports Strong H1 2025 Performance and Positive Outlook
3M ago
Hikma Pharmaceuticals Issues $500 Million in Guaranteed Notes
PremiumCompany Announcements
Hikma Pharmaceuticals Issues $500 Million in Guaranteed Notes
4M ago
Hikma Pharmaceuticals Discloses Managerial Share Disposal
PremiumCompany Announcements
Hikma Pharmaceuticals Discloses Managerial Share Disposal
5M ago
Hikma Pharmaceuticals Discloses Share Disposal by Key Executive
PremiumCompany Announcements
Hikma Pharmaceuticals Discloses Share Disposal by Key Executive
5M ago
Hikma Pharmaceuticals Announces Executive Share Vesting Under Incentive Plan
PremiumCompany AnnouncementsHikma Pharmaceuticals Announces Executive Share Vesting Under Incentive Plan
5M ago
Hikma Pharmaceuticals Receives Rating Upgrade from Fitch
Premium
Company Announcements
Hikma Pharmaceuticals Receives Rating Upgrade from Fitch
5M ago
Hikma Pharmaceuticals Executives Involved in Share Pledge Transactions
Premium
Company Announcements
Hikma Pharmaceuticals Executives Involved in Share Pledge Transactions
6M ago
Hikma Pharmaceuticals Projects Strong Growth and Rebrands Generics Business
PremiumCompany Announcements
Hikma Pharmaceuticals Projects Strong Growth and Rebrands Generics Business
6M ago
Hikma Pharmaceuticals Executives Acquire Shares Under DRIP
PremiumCompany Announcements
Hikma Pharmaceuticals Executives Acquire Shares Under DRIP
6M ago
Hikma Pharmaceuticals’ Credit Rating Upgraded by S&P
PremiumCompany Announcements
Hikma Pharmaceuticals’ Credit Rating Upgraded by S&P
6M ago
Hikma Pharmaceuticals Settles Xyrem® Antitrust Lawsuits in the U.S.
PremiumCompany Announcements
Hikma Pharmaceuticals Settles Xyrem® Antitrust Lawsuits in the U.S.
6M ago
Hikma Pharmaceuticals Announces Managerial Share Transactions
PremiumCompany AnnouncementsHikma Pharmaceuticals Announces Managerial Share Transactions
6M ago
Hikma Pharmaceuticals Successfully Concludes 2025 AGM with All Resolutions Passed
Premium
Company Announcements
Hikma Pharmaceuticals Successfully Concludes 2025 AGM with All Resolutions Passed
7M ago
Promising Financial Outlook and Strategic Positioning of Hikma Pharmaceuticals: A Buy Recommendation by Christian Glennie
Premium
Ratings
Promising Financial Outlook and Strategic Positioning of Hikma Pharmaceuticals: A Buy Recommendation by Christian Glennie
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >